Cargando…
Promising Colorectal Cancer Biomarkers for Precision Prevention and Therapy
Colorectal cancer (CRC) has been ranked as the third most prevalent cancer worldwide. Indeed, it represents 10.2% of all cancer cases. It is also the second most common cause of cancer mortality, and accounted for about 9.2% of all cancer deaths in 2018. Early detection together with a correct diagn...
Autores principales: | Turano, Mimmo, Delrio, Paolo, Rega, Daniela, Cammarota, Francesca, Polverino, Alessia, Duraturo, Francesca, Izzo, Paola, De Rosa, Marina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6966638/ https://www.ncbi.nlm.nih.gov/pubmed/31817090 http://dx.doi.org/10.3390/cancers11121932 |
Ejemplares similares
-
A Potential Role of IL-6/IL-6R in the Development and Management of Colon Cancer
por: Turano, Mimmo, et al.
Publicado: (2021) -
The Epithelial to Mesenchymal Transition in Colorectal Cancer Progression: The Emerging Role of Succinate Dehydrogenase Alterations and Succinate Accumulation
por: Turano, Mimmo, et al.
Publicado: (2023) -
Characterisation of mesenchymal colon tumour-derived cells in tumourspheres as a model for colorectal cancer progression
por: Turano, Mimmo, et al.
Publicado: (2018) -
Genetics, diagnosis and management of colorectal cancer (Review)
por: DE ROSA, MARINA, et al.
Publicado: (2015) -
Beta catenin and cytokine pathway dysregulation in patients with manifestations of the "PTEN hamartoma tumor syndrome"
por: Galatola, Martina, et al.
Publicado: (2012)